Wave of New BACE Inhibitors Heading to Phase 2
inhibitors. It’s just a note of caution as we move forward with these compounds in clinical trials.”—Esther
379 RESULTS
You searched Esther
Sort By:
inhibitors. It’s just a note of caution as we move forward with these compounds in clinical trials.”—Esther
going to give us new handles on investigating the neuropathology of diseases like AD.”—Esther Landhuis
at seeding aggregation.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3191
PD, whereas by virtue of its binding SorLA, Vps26 is more linked to APP and AD.—Esther Landhuis None
actually present in the brain after injection," wrote Hsiao and colleagues.—Esther Landhuis None
diseases such as Alzheimer’s (see ARF related news story).—Esther Landhuis None
does a nice job addressing these issues.”—Esther Landhuis None
though that is beginning to change.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3159
cholesterol but on the whole [mevalonate] pathway. The implications of that could be detrimental.”—Esther
did not own. The patents at the center of this controversy expire next year.—Esther Landhuis. None
related news story on Galasko et al., 2010).—Esther Landhuis None
underpowered to find association with AD genes.” —Esther Landhuis None
receptors is currently used to treat PD patients with dyskinesias.—Esther Landhuis None
more mechanistic work and trying to design analogs, Barnham said.—Esther Landhuis None
dementia with parkinsonism-17 (FTDP-17).—Esther Landhuis None